Pipeline overview

Forward Pharma has established a pipeline of immunomodulatory compounds with the potential to mature into a family of development programs in multiple indications with several different chemical entities.

Forward Pharma's key focus is on the lead drug candidate, FP 187, which has completed clinical phase I.